Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement

David W. Self, David A. Karanian, Jennifer J. Spencer

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Selective D1 dopamine agonists represent a potential pharmacotherapy for the treatment of cocaine addiction. Here we report that systemic injections of the novel D1 agonist ABT-431 lack the ability to induce cocaine-seeking behavior, and completely attenuate the ability of cocaine to induce this behavior in rats tested in a reinstatement paradigm. Similar doses suppress the initiation of cocaine self-administration, and produce an extinction-like response pattern in animals that subsequently initiate self-administration, without altering responding maintained by food pellets. There was no tolerance to this effect over 4 days of testing. The results suggest that ABT-431 attenuates the motivation to seek cocaine, and masks the reinforcing effects of cocaine during self-administration. The profile of ABT-431 is similar to the behavioral effects of other structurally distinct D1 agonists, and is consistent with the desired profile of a 'methadone-like' compound for cocaine addiction.

Original languageEnglish (US)
Pages (from-to)133-144
Number of pages12
JournalAnnals of the New York Academy of Sciences
Volume909
StatePublished - 2000

Fingerprint

Self Administration
Dopamine Agonists
Cocaine
Cocaine-Related Disorders
Aptitude
Methadone
Masks
Drug therapy
Motivation
adrogolide hydrochloride
Dopamine
Drug Therapy
Food
Rats
Injections
Animals
Testing

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement. / Self, David W.; Karanian, David A.; Spencer, Jennifer J.

In: Annals of the New York Academy of Sciences, Vol. 909, 2000, p. 133-144.

Research output: Contribution to journalArticle

@article{109414969c8a4483929966599d0d4c85,
title = "Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement",
abstract = "Selective D1 dopamine agonists represent a potential pharmacotherapy for the treatment of cocaine addiction. Here we report that systemic injections of the novel D1 agonist ABT-431 lack the ability to induce cocaine-seeking behavior, and completely attenuate the ability of cocaine to induce this behavior in rats tested in a reinstatement paradigm. Similar doses suppress the initiation of cocaine self-administration, and produce an extinction-like response pattern in animals that subsequently initiate self-administration, without altering responding maintained by food pellets. There was no tolerance to this effect over 4 days of testing. The results suggest that ABT-431 attenuates the motivation to seek cocaine, and masks the reinforcing effects of cocaine during self-administration. The profile of ABT-431 is similar to the behavioral effects of other structurally distinct D1 agonists, and is consistent with the desired profile of a 'methadone-like' compound for cocaine addiction.",
author = "Self, {David W.} and Karanian, {David A.} and Spencer, {Jennifer J.}",
year = "2000",
language = "English (US)",
volume = "909",
pages = "133--144",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement

AU - Self, David W.

AU - Karanian, David A.

AU - Spencer, Jennifer J.

PY - 2000

Y1 - 2000

N2 - Selective D1 dopamine agonists represent a potential pharmacotherapy for the treatment of cocaine addiction. Here we report that systemic injections of the novel D1 agonist ABT-431 lack the ability to induce cocaine-seeking behavior, and completely attenuate the ability of cocaine to induce this behavior in rats tested in a reinstatement paradigm. Similar doses suppress the initiation of cocaine self-administration, and produce an extinction-like response pattern in animals that subsequently initiate self-administration, without altering responding maintained by food pellets. There was no tolerance to this effect over 4 days of testing. The results suggest that ABT-431 attenuates the motivation to seek cocaine, and masks the reinforcing effects of cocaine during self-administration. The profile of ABT-431 is similar to the behavioral effects of other structurally distinct D1 agonists, and is consistent with the desired profile of a 'methadone-like' compound for cocaine addiction.

AB - Selective D1 dopamine agonists represent a potential pharmacotherapy for the treatment of cocaine addiction. Here we report that systemic injections of the novel D1 agonist ABT-431 lack the ability to induce cocaine-seeking behavior, and completely attenuate the ability of cocaine to induce this behavior in rats tested in a reinstatement paradigm. Similar doses suppress the initiation of cocaine self-administration, and produce an extinction-like response pattern in animals that subsequently initiate self-administration, without altering responding maintained by food pellets. There was no tolerance to this effect over 4 days of testing. The results suggest that ABT-431 attenuates the motivation to seek cocaine, and masks the reinforcing effects of cocaine during self-administration. The profile of ABT-431 is similar to the behavioral effects of other structurally distinct D1 agonists, and is consistent with the desired profile of a 'methadone-like' compound for cocaine addiction.

UR - http://www.scopus.com/inward/record.url?scp=0033623870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033623870&partnerID=8YFLogxK

M3 - Article

C2 - 10911927

AN - SCOPUS:0033623870

VL - 909

SP - 133

EP - 144

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -